208 related articles for article (PubMed ID: 27594784)
41. Epidemiological characteristics of chronic fatigue syndrome/myalgic encephalomyelitis in Australian patients.
Johnston SC; Staines DR; Marshall-Gradisnik SM
Clin Epidemiol; 2016; 8():97-107. PubMed ID: 27279748
[TBL] [Abstract][Full Text] [Related]
42. Regulatory T, natural killer T and γδ T cells in multiple sclerosis and chronic fatigue syndrome/myalgic encephalomyelitis: a comparison.
Ramos S; Brenu E; Broadley S; Kwiatek R; Ng J; Nguyen T; Freeman S; Staines D; Marshall-Gradisnik S
Asian Pac J Allergy Immunol; 2016 Dec; 34(4):300-305. PubMed ID: 27001659
[TBL] [Abstract][Full Text] [Related]
43. Antibody-Dependent Cell-mediated Cytotoxicity (ADCC) in Familial Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
Sung AP; Tang JJ; Guglielmo MJ; Smith-Gagen J; Bateman L; Navarrete-Galvan L; Redelman DD; Hudig D
Fatigue; 2020; 8(4):226-244. PubMed ID: 33777500
[TBL] [Abstract][Full Text] [Related]
44. Impaired Health-Related Quality of Life in Adolescent Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Impact of Core Symptoms.
Roma M; Marden CL; Flaherty MAK; Jasion SE; Cranston EM; Rowe PC
Front Pediatr; 2019; 7():26. PubMed ID: 30828572
[No Abstract] [Full Text] [Related]
45. Current Research Provides Insight into the Biological Basis and Diagnostic Potential for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
Sweetman E; Noble A; Edgar C; Mackay A; Helliwell A; Vallings R; Ryan M; Tate W
Diagnostics (Basel); 2019 Jul; 9(3):. PubMed ID: 31295930
[TBL] [Abstract][Full Text] [Related]
46. Anxiety and depression in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): Examining the incidence of health anxiety in CFS/ME.
Daniels J; Brigden A; Kacorova A
Psychol Psychother; 2017 Sep; 90(3):502-509. PubMed ID: 28244209
[TBL] [Abstract][Full Text] [Related]
47. Medically Documenting Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Cases.
Comerford BB; Podell R
Front Pediatr; 2019; 7():231. PubMed ID: 31334205
[TBL] [Abstract][Full Text] [Related]
48. Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
de Vega WC; Herrera S; Vernon SD; McGowan PO
BMC Med Genomics; 2017 Feb; 10(1):11. PubMed ID: 28231836
[TBL] [Abstract][Full Text] [Related]
49. Neuroinflammation in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: An ¹¹C-(R)-PK11195 PET Study.
Nakatomi Y; Mizuno K; Ishii A; Wada Y; Tanaka M; Tazawa S; Onoe K; Fukuda S; Kawabe J; Takahashi K; Kataoka Y; Shiomi S; Yamaguti K; Inaba M; Kuratsune H; Watanabe Y
J Nucl Med; 2014 Jun; 55(6):945-50. PubMed ID: 24665088
[TBL] [Abstract][Full Text] [Related]
50. The expression signature of very long non-coding RNA in myalgic encephalomyelitis/chronic fatigue syndrome.
Yang CA; Bauer S; Ho YC; Sotzny F; Chang JG; Scheibenbogen C
J Transl Med; 2018 Aug; 16(1):231. PubMed ID: 30119681
[TBL] [Abstract][Full Text] [Related]
51. Metabolic abnormalities in chronic fatigue syndrome/myalgic encephalomyelitis: a mini-review.
Tomas C; Newton J
Biochem Soc Trans; 2018 Jun; 46(3):547-553. PubMed ID: 29666214
[TBL] [Abstract][Full Text] [Related]
52. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians.
Bested AC; Marshall LM
Rev Environ Health; 2015; 30(4):223-49. PubMed ID: 26613325
[TBL] [Abstract][Full Text] [Related]
53. A targeted genome association study examining transient receptor potential ion channels, acetylcholine receptors, and adrenergic receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
Johnston S; Staines D; Klein A; Marshall-Gradisnik S
BMC Med Genet; 2016 Nov; 17(1):79. PubMed ID: 27835969
[TBL] [Abstract][Full Text] [Related]
54. In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation.
Maes M; Ringel K; Kubera M; Anderson G; Morris G; Galecki P; Geffard M
J Affect Disord; 2013 Sep; 150(2):223-30. PubMed ID: 23664637
[TBL] [Abstract][Full Text] [Related]
55. Inflammatory and oxidative and nitrosative stress cascades as new drug targets in myalgic encephalomyelitis and chronic fatigue syndrome.
Maes M
Mod Trends Pharmacopsychiatry; 2013; 28():162-74. PubMed ID: 25224898
[TBL] [Abstract][Full Text] [Related]
56. A Systematic Review of Drug Therapies for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
Collatz A; Johnston SC; Staines DR; Marshall-Gradisnik SM
Clin Ther; 2016 Jun; 38(6):1263-1271.e9. PubMed ID: 27229907
[TBL] [Abstract][Full Text] [Related]
57. Poor sleep quality is associated with greater circulating pro-inflammatory cytokines and severity and frequency of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) symptoms in women.
Milrad SF; Hall DL; Jutagir DR; Lattie EG; Ironson GH; Wohlgemuth W; Nunez MV; Garcia L; Czaja SJ; Perdomo DM; Fletcher MA; Klimas N; Antoni MH
J Neuroimmunol; 2017 Feb; 303():43-50. PubMed ID: 28038892
[TBL] [Abstract][Full Text] [Related]
58. A systematic review of cytokines in chronic fatigue syndrome/myalgic encephalomyelitis/systemic exertion intolerance disease (CFS/ME/SEID).
Corbitt M; Eaton-Fitch N; Staines D; Cabanas H; Marshall-Gradisnik S
BMC Neurol; 2019 Aug; 19(1):207. PubMed ID: 31445522
[TBL] [Abstract][Full Text] [Related]
59. A Preliminary Comparative Assessment of the Role of CD8+ T Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis.
Brenu EW; Broadley S; Nguyen T; Johnston S; Ramos S; Staines D; Marshall-Gradisnik S
J Immunol Res; 2016; 2016():9064529. PubMed ID: 26881265
[TBL] [Abstract][Full Text] [Related]
60. Intermittent and graded exercise effects on NK cell degranulation markers LAMP-1/LAMP-2 and CD8
Broadbent S; Coutts R
Physiol Rep; 2017 Mar; 5(5):. PubMed ID: 28275109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
